Curt Labelle

Dr. LaBelle has been investing in and working with healthcare companies for two decades. As the Founding Partner and Chair of Global Health Funds, Dr. LaBelle oversees the private investments portfolio, delivering life-changing therapeutics and diagnostics worldwide for conditions such as cholera, cataract-induced blindness, snakebites, tuberculosis, HIV, and postpartum hemorrhage. He has served on the Boards of Directors of Sirion Therapeutics, Eyenovia, KAI Pharmaceuticals, Alydia, and other notable companies. Dr. LaBelle holds a dual MD/MBA degree from Columbia University.